Next Article in Journal
Diagnostic and Prognostic Potential of Biomarkers CYFRA 21.1, ERCC1, p53, FGFR3 and TATI in Bladder Cancers
Previous Article in Journal
Correction: Al-Zamel, N., et al. A Dual GLP-1/GIP Receptor Agonist Does Not Antagonize Glucagon at Its Receptor but May Act as a Biased Agonist at the GLP-1 Receptor. Int. J. Mol. Sci. 2019, 20, 3532.
 
 
Article

Article Versions Notes

Int. J. Mol. Sci. 2020, 21(9), 3361; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms21093361
Action Date Notes Link
article xml file uploaded 9 May 2020 15:29 CEST Original file -
article xml uploaded. 9 May 2020 15:29 CEST Update https://0-www-mdpi-com.brum.beds.ac.uk/1422-0067/21/9/3361/xml
article pdf uploaded. 9 May 2020 15:29 CEST Version of Record https://0-www-mdpi-com.brum.beds.ac.uk/1422-0067/21/9/3361/pdf
article supplementary file uploaded. 9 May 2020 15:29 CEST - https://0-www-mdpi-com.brum.beds.ac.uk/1422-0067/21/9/3361#supplementary
article html file updated 9 May 2020 15:30 CEST Original file -
article html file updated 23 May 2020 10:16 CEST Update -
article html file updated 21 July 2022 04:22 CEST Update https://0-www-mdpi-com.brum.beds.ac.uk/1422-0067/21/9/3361/html
Back to TopTop